Nektar Therapeutics shares owned by Ubs Global Asset Management Americas
Quarter-by-quarter ownership of Nektar Therapeutics (NKTR) shares owned by Ubs Global Asset Management Americas
from 13F filings
Historical chart of Ubs Global Asset Management Americas investment in Nektar Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Nektar Therapeutics held by Ubs Global Asset Management Americas consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Nektar Therapeutics by Ubs Global Asset Management Americas
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2026-03-31 | $2.4M | 34k | 71.95 |
| 2025-12-31 | $684k | 16k | 42.28 |
More positions owned by Ubs Global Asset Management Americas
View all positions for Ubs Global Asset Management Americas